Rhenman & Partners Asset Management AB grew its holdings in Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 66.1% during the third quarter, Holdings Channel.com reports. The firm owned 166,061 shares of the company’s stock after buying an additional 66,061 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Immunovant were worth $6,375,000 […]